“HIGH-COST MEDICATIONS IN THE SUS: COPD PATIENTS IN A VULNERABLE STATE”. Editora Impacto Científico, Sept. 2025, pp. 211-9, https://doi.org/10.56238/edimpacto2025.028-022.